Precision BioSciences Inc (DTIL)
12.33
+0.35
(+2.92%)
USD |
NASDAQ |
May 17, 16:00
12.33
0.00 (0.00%)
After-Hours: 20:00
Precision BioSciences Debt to Equity Ratio: 0.6037 for March 31, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
March 31, 2024 | 0.6037 |
December 31, 2023 | 1.188 |
September 30, 2023 | 0.7695 |
June 30, 2023 | 0.6556 |
March 31, 2023 | 0.5543 |
December 31, 2022 | 0.3677 |
September 30, 2022 | 0.2628 |
June 30, 2022 | 0.2147 |
March 31, 2022 | 0.0356 |
December 31, 2021 | 0.0272 |
September 30, 2021 | 0.0242 |
Date | Value |
---|---|
June 30, 2021 | 0.0242 |
March 31, 2021 | 0.00 |
December 31, 2020 | 0.00 |
September 30, 2020 | 0.00 |
June 30, 2020 | 0.00 |
March 31, 2020 | 0.00 |
December 31, 2019 | 0.00 |
September 30, 2019 | 0.00 |
June 30, 2019 | 0.00 |
March 31, 2019 | 4.842 |
December 31, 2018 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Jun 2019
1.188
Maximum
Dec 2023
0.2364
Average
0.0257
Median
Debt to Equity Ratio Benchmarks
Altimmune Inc | 0.00 |
BioVie Inc | -- |
Adial Pharmaceuticals Inc | -- |
Gritstone Bio Inc | 2.888 |
Humacyte Inc | -- |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 184.74M |
Total Liabilities (Quarterly) | 147.54M |
Shareholders Equity (Quarterly) | 37.21M |
Current Ratio | 4.824 |
Net Debt Paydown Yield | -0.05% |